Home Biosimilar Antibodies Immunology & Inflammation CD markers antibody Brentuximab (Anti-TNFRSF8 / CD30) For research use only.
Not for use in humans.

Brentuximab (Anti-TNFRSF8 / CD30)

Synonyms:

Brentuximab (Anti-TNFRSF8 / CD30) is a chimeric monoclonal antibody targeting anti-CD30 with antineoplastic activity. It has the potential to alter the disease course of non-MF/SS CTCLs. MW : 145.38 KD.

Brentuximab (Anti-TNFRSF8 / CD30)

Purity & Quality Control

Batch: A232201 Purity: 99% Protein concentration: 4.46mg/ml Endotoxin Level: ＜1EU/mg
99

Choose Selective CD markers Inhibitors

Biological Activity

Description Brentuximab (Anti-TNFRSF8 / CD30) is a chimeric monoclonal antibody targeting anti-CD30 with antineoplastic activity. It has the potential to alter the disease course of non-MF/SS CTCLs. MW : 145.38 KD.

Product Details

CAS No. 2088770-90-3
Molecular Weight 145.38 kDa
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Brentuximab (Anti-TNFRSF8 / CD30) | Brentuximab (Anti-TNFRSF8 / CD30) supplier | purchase Brentuximab (Anti-TNFRSF8 / CD30) | Brentuximab (Anti-TNFRSF8 / CD30) cost | Brentuximab (Anti-TNFRSF8 / CD30) manufacturer | order Brentuximab (Anti-TNFRSF8 / CD30) | Brentuximab (Anti-TNFRSF8 / CD30) distributor